U.S. sales levels for many widely used drug categories shifted significantly in 2012, with sales in some classes declining sharply due to an infusion of cheaper new generic pills. Other categories grew, mainly with the introduction of new, generally expensive medicines.
Here’s a look at U.S. sales of the top-grossing drug categories in 2012:
DRUG CATEGORY 2012spendingChangefrom2011
Cancer medicines $25.9billionUp7.8percent
Mental illness $23.5billionDown21percent
Respiratory disorders $22.1billionUp1.9percent
Diabetes medicines $22billionUp7.1percent
Cholesterol/lipid drugs $16.9billionDown20.6percent
Immune disorders $14.8billionUp17.9percent
High blood pressure $13.6billionDown3percent
HIV/AIDS medicines $11.7billionUp12.1percent
Attention deficit disorder $10.4billionUp13.1percent
Ulcer medicines $10billionDown4.7percent
Multiple sclerosis drugs $8.9billionUp17.8percent
Nervous system disorders $7.2billionup3.7percent
Source: IMS Institute for Healthcare Informatics.